Join the Uterine Leiomyomata / Fibroids group to help and get support from people like you.
Uterine Leiomyomata / Fibroids News
Related terms: Uterine Fibroid, Fibroid
Exercise Beneficial to Mental Health of Women With Chronic Pelvic Pain
TUESDAY, March 4, 2025 – Engaging in physical activity seems to be beneficial to the mental health of women with chronic pelvic pain disorders (CPPD), according to a study published online Feb. 26...
Exercise Boosts Mental Health Of Women With Chronic Pelvic Pain
MONDAY, March 3, 2025 – Physical activity can improve the mental well-being of women living with chronic pelvic pain disorders like endometriosis and uterine fibroids, a new study says. Activities...
Risk for Premature Mortality Increased With History of Endometriosis
THURSDAY, Nov. 21, 2024 – Women with a history of endometriosis and uterine fibroids may have an increased risk for premature mortality, according to a study published online Nov. 20 in The BMJ....
Fibroids, Endometriosis Linked to Shorter Life Spans
FRIDAY, Nov. 22, 2024 — Two conditions common during women's childbearing years may increase their odds for serious illness and premature death, a large study shows. Drawing on data from close to 1...
Uterus Transplant Feasible, Linked to High Rate of Live Birth
MONDAY, Aug. 19, 2024 – Uterus transplant is feasible and is associated with high rates of live birth after successful graft survival, according to a study published online Aug. 15 in the Journal of...
FDA Approves Myfembree as the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids
BASEL, Switzerland and NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) – Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Oriahnn (elagolix/estradiol/norethindrone acetate and elagolix) for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-Menopausal Women
NORTH CHICAGO, Ill., May 29, 2020 /PRNewswire/ – AbbVie (NYSE: ABBV), in cooperation with Neurocrine Biosciences, Inc. (Nasdaq: NBIX), announced that the U.S. Food and Drug Administration (FDA)...